Advertise
Urology Times® offers custom-designed programs to fit the needs of your brand. By utilizing our omnichannel marketing levers you will have access to our highly engaged audience and receive guaranteed, quality results.
Let's work together - Contact Us!
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves lutetium Lu 177 vipivotide tetraxetan for PSMA-positive mHSPC
2
Individualizing androgen pathway therapy in mCSPC
3
Large registry study reports durable 10-year outcomes with focal therapy for prostate cancer
4
Testosterone deficiency: FAQs from the AUA guideline
5